Fulgent Therapeutics

About:

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.

Website: https://www.fulgentgenetics.com/

Twitter/X: FulgentInfo

Description:

Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients.

Total Funding Amount:

$34.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Temple City, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)fulgent-therapeutics.com

Founders:

Ming Hsieh

Number of Employees:

1001-5000

Last Funding Date:

2016-05-24

IPO Status:

Public

Industries:

© 2025 bioDAO.ai